Iterum Therapeutics Plc (ITRM) Tops Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts ITRM Hot Sheet
Join SI Premium – FREE
Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q4 EPS of ($0.12), $0.10 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- UBS Starts Internet Initiative Japan Inc (3774:JP) (IIJIY) at Neutral
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
